Yan Li

Yan Li


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
LLLinying Liu
Linying Liu
YLYan Li
Yan Li
HPHuan Peng
Huan Peng
RLRuiyuan Liu
Ruiyuan Liu
WJWeihong Ji
Weihong Ji
Xin ZhangXin Zhang
Xin Zhang
The most critical problem in the treatment of neurodegenerative diseases is brain neuronal protection, which can be overcome by clearing pathological substances and regulating the immune environment. In the above treatment strategies, the traditional poor drug delivery problem is inevitable. Here, we show an engineering core-shell hybrid system named rabies virus glycoprotein (RVG) peptide–modified exosome (EXO) curcumin/phenylboronic acid-poly(2-(dimethylamino)ethyl acrylate) nanoparticle/small interfering RNA targeting SNCA (REXO-C/ANP/S). It is a nanoscavenger for clearing α-synuclein aggregates and reducing their cytotoxicity in Parkinson’s disease neurons. The motor behavior of Parkinson’s disease mice is substantially improved after REXO-C/ANP/S treatment. In particular, we demonstrate that REXO-C/ANP/S is also a nanoscavenger for clearing immune activation due to its natural immature dendritic cell EXO coating. Our findings show that REXO-C/ANP/S may serve as a platform for neurodegenerative diseases treatment.

28 February 2022 in Bioactive Materials
Verified
Journal Article
Open access
YLYan Li
Yan Li
WZWen Zhang
Wen Zhang
RZRuichen Zhao
Ruichen Zhao
Xin ZhangXin Zhang
Xin Zhang
Peptide drugs play an important role in diabetes mellitus treatment. Oral administration of peptide drugs is a promising strategy for diabetes mellitus because of its convenience and high patient compliance compared to parenteral administration routes. However, there are a series of formidable unfavorable conditions present in the gastrointestinal (GI) tract after oral administration, which result in the low oral bioavailability of these peptide drugs. To overcome these challenges, various nanoparticles (NPs) have been developed to improve the oral absorption of peptide drugs due to their unique in vivo properties and high design flexibility. This review discusses the unfavorable conditions present in the GI tract and provides the corresponding strategies to overcome these challenges. The review provides a comprehensive overview on the NPs that have been constructed for oral peptide drug delivery in diabetes mellitus treatment. Finally, we will discuss the rational application and give some suggestions that can be utilized for the development of oral peptide drug NPs. Our aim is to provide a systemic and comprehensive review of oral peptide drug NPs that can overcome the challenges in GI tract for efficient treatment of diabetes mellitus.

31 January 2023 in Chinese Chemical Letters
Verified
Journal Article
Closed access
MLMuzi Li
Muzi Li
WZWen Zhang
Wen Zhang
JLJiaxin Li
Jiaxin Li
YQYinghe Qi
Yinghe Qi
CPChen Peng
Chen Peng
YLYan Li
Yan Li

8 November 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JLJiaxin Li
Jiaxin Li
HPHuan Peng
Huan Peng
WZWen Zhang
Wen Zhang
MLMuzi Li
Muzi Li
NWNan Wang
Nan Wang
YLYan Li
Yan Li

4 December 2024 in Small
Verified
Journal Article
Closed access
JLJiaxin Li
Jiaxin Li
NWNan Wang
Nan Wang
WZWen Zhang
Wen Zhang
CPChen Peng
Chen Peng
XZXinyue Zhang
Xinyue Zhang
YLYan Li
Yan Li

1 January 2024 in Theranostics
Verified
Journal Article
Open access
PDF file
MLMuzi Li
Muzi Li
NWNan Wang
Nan Wang
RLRuiyuan Liu
Ruiyuan Liu
XZXinyue Zhang
Xinyue Zhang
WHWei He
Wei He
YLYan Li
Yan Li
Background: Oral insulin delivery is considered a revolutionary alternative to daily subcutaneous injection. However, the oral bioavailability of insulin is very low due to the poor oral absorption into blood circulation.